Edit
Cellnovo Group
http://www2.cellnovo.com/Last activity: 02.04.2024
Probably Closed - Reference to Indosatooredoo Netsafe
Cellnovo is an innovative medical technology company specialising in diabetes. The company develops and markets The Cellnovo System, the world's first mobile, connected, all-in-one diabetes management system that helps make life easier for people with type 1 diabetes. Compact, intuitive and entirely connected, Cellnovo’s micro-pump for insulin delivery communicates wirelessly with a locked-down Android phone, offering the quality and responsiveness that is to be expected from consumer-grade smartphones, while preserving the high-level of security of a medical-grade device. This unique device allows optimal management of diabetes whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real time.
The current version of the system has received CE Mark approval and is reimbursed and available in 10 countries: France, the United Kingdom, The Netherlands, Italy, Spain, Australia, New Zealand, Israel, Greece and Cyprus. Cellnovo has a clearly-defined expansion strategy that involves accelerating the product’s commercialisation, initially in Europe and then in the United States and Asia, and increasing its production capacity to respond to a high level of demand. For more information, visit www.cellnovo.com.
The current version of the system has received CE Mark approval and is reimbursed and available in 10 countries: France, the United Kingdom, The Netherlands, Italy, Spain, Australia, New Zealand, Israel, Greece and Cyprus. Cellnovo has a clearly-defined expansion strategy that involves accelerating the product’s commercialisation, initially in Europe and then in the United States and Asia, and increasing its production capacity to respond to a high level of demand. For more information, visit www.cellnovo.com.
Location: France, Ile-de-France, Paris
Employees: 51-200
Total raised: $48.28M
Founded date: 2002
Investors 4
| Date | Name | Website |
| - | Auriga Par... | auriga.vc |
| - | Forbion | forbion.co... |
| - | Andera Par... | anderapart... |
| - | Advent Lif... | adventls.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.02.2011 | Series B | $48.28M | - |
Mentions in press and media 7
| Date | Title | Description |
| 02.04.2024 | Gilbane, Inc. Announces Appointment of William F. McKeon to Board of Directors | William F. McKeon, President & CEO of the Texas Medical Center, joins Gilbane, Inc.'s Board of Directors. (PRNewsfoto/Gilbane, Inc.) Healthcare chief executive brings global life sciences expertise to Gilbane, a leader in construction s... |
| 17.08.2016 | 12 of the Most Exciting Welsh Startups of 2016 | This article was originally posted on the Tech City UK website. Tech Nation 2016 found well over 43,000 jobs in the Welsh digital tech economy and a digital GVA of around £600m. We hear about 12 exciting Welsh startups currently working wi... |
| 09.02.2012 | Device makers plan to offset tax burden by raising prices | MassDevice.com On Call | MASSDEVICE ON CALL — Most small medical device companies may deal with the added burden of the impending 2.3% medical device tax by passing the cost onto customers, an industry survey found. Of 180 device industry executives surveyed, about... |
| 04.02.2011 | Cellnovo Raises £30M Series B Funding Round | Cellnovo, a London, UK-based developer of a mobile diabetes management system, raised £30m (approximately $48.4m) in a Series B round of funding. The round was led by Edmond de Rothschild Investment Partners, with participation from Forbion... |
| 04.02.2011 | Diabetes management system could be ‘iTunes of diabetes care’ | Previous investors Advent Venture Partners, HealthCare Ventures and NESTA also participated in the round, according to a prepared release. Cellnovo officials said they would use the proceeds to commercialize and expand markets for its diabe... |
| 04.02.2011 | Cellnovo raises $48 million to commercialize “itunes of diabetes care” | Cellnovo announced its presence as a major player in the diabetes race with $48 million in new funding for what industry observers have called the “iTunes of diabetes care.” The B round for the London-based company was led by Edmond de Roth... |
| - | Diabetes management system could be ‘iTunes of diabetes care’ | London-based Cellnovo closes $48 million B round to fund commercialization of the first all mobile diabetes management system, which is drawing comparisons to Apple Inc.’s blockbuster iPhone and iPod platforms. Cellnovo announced its presen... |